Artyom A Egorov, Desislava S Makeeva, Nadezhda E Makarova, Dmitri A Bykov, Yanislav S Hrytseniuk, Olga V Mitkevich, Valery N Urakov, Alexander I Alexandrov, Ivan V Kulakovskiy, Sergey E Dmitriev
Article in F1000Research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 50% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
1 citing paper in PubMed, 2 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
10 authors at 4 institutions in 1 country.
Artyom A EgorovPhystech School of Biological and Medical Physics, Moscow Institute of Physics and Technology (State University), Dolgoprudny, 141700, Russian Federation.ORCID 0000-0001-5578-5384
Desislava S MakeevaBelozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow, 119234, Russian Federation.
Nadezhda E MakarovaBelozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow, 119234, Russian Federation.
Dmitri A BykovBelozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow, 119234, Russian Federation.
Yanislav S HrytseniukBelozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow, 119234, Russian Federation.
Olga V MitkevichBach Institute of Biochemistry, FRC of Biotechnology of the Russian Academy of Sciences, Moscow, 119071, Russian Federation.
Valery N UrakovBach Institute of Biochemistry, FRC of Biotechnology of the Russian Academy of Sciences, Moscow, 119071, Russian Federation.
Alexander I AlexandrovBach Institute of Biochemistry, FRC of Biotechnology of the Russian Academy of Sciences, Moscow, 119071, Russian Federation.
Ivan V KulakovskiyBelozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow, 119234, Russian Federation.
Sergey E DmitrievBelozersky Institute of Physico-Chemical Biology, Lomonosov Moscow State University, Moscow, 119234, Russian Federation.ORCID 0000-0002-1774-8475
Lomonosov Moscow State University · RUA N Bach Institute of Biochemistry · RUEngelhardt Institute of Molecular Biology · RUMoscow Institute of Physics and Technology · RU
Funding
No grant is acknowledged in the PubMed record.
6 · The paper itself
Abstract
In eukaryotes, stalled and collided ribosomes are recognized by several conserved multicomponent systems, which either block protein synthesis
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.
Ribo-Seq and RNA-Seq of · full record | OpenQuestion